As you might be able to tell, I’ve long thought that most popular emo rap was bad, but the one tape for which I still have a soft spot is Lil Peep’s Crybaby. Released in 2016, Peep, like Gates, ...

CenterPoint Energy CNP benefits from rising electricity consumption, driven by the rapid electrification of transportation and buildings, along with increasing investments in renewable energy. Given ...

Complete with black Christmas trees, themed drinks and a pop punk playlist of dreams, Brooklyn’s Emo Christmas pop-up is proving that it was never just a phase. Rock music afficionado can immerse ...

A Texas deer seemingly embracing its “emo era” is “totally fine,” the Lago Vista Police Department has assured concerned residents. In a humorous Facebook post on October 25, the department shared a ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

The best Midwest emo albums of the 1990s were contained within the actual Midwest, for the most part. Fast forward to more recent years and we've seen bands from just about every corner of the U.S.

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary ...

I rate EMO a strong buy due to its focused exposure to booming natural gas exports and resilient midstream infrastructure, supporting both income and growth. The fund’s concentrated portfolio targets ...

Jazmin Kylene is a Miami-bred writer and editor with a decade-long career that spans all editorial genres, though she has a particular passion for music journalism. Upon graduating Florida Atlantic ...

While the last solid wave of emo music ended in the 2000s, that era of angsty rock music will never truly die. In fact, quite a few albums from that era are starting to get discovered by the new ...

A Prescription Drug User Fee Act target date of November 30, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application ...